WATTON COREY MICHAEL purchased 81.3% of their position (325.00 shares) of ZEVRA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $1.8K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/13/2023ACC: 0001437749-23-017335
Director
Since Apr 2023
+325.00
Net shares
Net buyer
$1.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
325.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+325.00
Price / share
$5.52
Trade value
$1.79K
% of position
81.3%
6/9/2023
400.00→725.00
Total
Net shares
+325.00
Net value
$1.79K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/9/2023 | P · Purchase | +325.00 | $5.52 | $1.79K | 81.3% | 400.00 | 725.00 |
| Total | +325.00 | $1.79K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned400.00
Total
400.00 direct400.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 400.00 | Direct |
| Total | 400.00 | 400.00 direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported